Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ConforMIS Inc (CFMS) Up 29% On Second Day of Trading

The shares of ConforMIS Inc (NASDAQ:CFMSare trading 29% higher on their second day of trading after rising 5.42% on the opening day. The medical technology company started trading on the NASDAQ on July 1 with a total of 39.06 million common shares. The market capitalization of ConforMIS reached $826.02 million after the initial boost.

It is known for manufacturing joint replacement implants for individual patients with the help of its iFit Image-to-Implant technology. According to ConforMIS Inc (NASDAQ:CFMS)’s S-1 filing, its net revenue for the first quarter stood at $14.7 million, while its net loss amounted to $3.32 per share, above the loss of $3.04 per share a year ago.

Earlier, ConforMIS Inc (NASDAQ:CFMS) announced that it planned to sell 9.0 million shares at $15.00 per share in the IPO, with additional 1.35 million additional shares as over-allotment options. The offering is expected to close on July 7.


According to the company’s S-1 filing, Procific, Veron International Limited, and SGR Sagittarius Holding AG and Aeries Capital Archer L.P. are among the principal stockholders of the company, holding 8.00%, 7.53% and 9.79% of the outstanding stock after the IPO. The management of ConforMIS Inc (NASDAQ:CFMS) includes Dr. Philipp Lang, founder, President, and Chief Executive Officer of the company, while Paul Weiner is the Chief Financial Officer and Dr. Daniel Steines is serving as the Chief Technology Officer of the company.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.